We must optimize stent deployment & maintain a registry of how well (or poorly) we use drug-eluting stents. Instead of asking “Which stent?” or “How much anti-platelet therapy?” we must ask “How effectively are we deploying our stents?”
Design of Clinical Trials for Treatment of Pain, Development of Clinical Trials, Selected Qualitative Methods, Within-Patient Studies: Cross-over Trials & n-of-1 Studies, Clinical Economics, etc.